. . . . . "Pharmacogenomics-guided clopidogrel strategy represents a cost-effective treatment for patients undergoing PCI" . . . . . . . . . . . "Our data show that pharmacogenomics-guided clopidogrel treatment strategy may represent a cost-effective choice compared with non-pharmacogenomics-guided strategy for patients undergoing PCI." . . "RSA" . "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCJlM78d80R+gFMoQB1IG3f7AbqqGOCIv4HmZd1cx1KgEWMUUpPsojFNvx84fC/TltcJ8F8JafnbhDXW2HM2MhdK4yC04ROEV1vIgSzjDicHfiqXvMqdPuMyQp4mmCEY7mUoeEW10mWZqjk+S9TnmiAQbFGcpExP8aosr2aTR7CSQIDAQAB" . "cEQZgFxgTd99RYcmWsqM1LCUciLc1lXuy6mfjgKhn0BfsMcesqIKR+51xx6lfHD31tnz/bovIDh1YEPORGBe2PEvFMPvRRFd67B9s1awepEPll5tA7wmhkTOjPrEUXISQaQu93NbpbYMYSGnRx+Shv7jNxE+hPrxQw7fD6EgJr8=" . . "2021-11-17T21:22:59.625+02:00"^^ . . . . . . . . . . .